SCN1A and Alzheimer disease: For example, AD models have shown that pathological Aβ inhibits extracellular glutamate reuptake48 and interferes with GABAergic inhibitory neurotransmission including downregulation of Nav1.1 channels in parvalbumin-positive interneurons4,49.